Interventional Gastroenterology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.
Curr Drug Metab. 2020;21(4):256-259. doi: 10.2174/1389200221666200420100129.
The liver represents the major site of drug metabolism, i.e. the key organ in the processes of detoxification and elimination of drugs from the organism. It is therefore often affected by toxic metabolites and suffers sometimes fatal consequences. The spectrum of pathologies differs by the cell type primarily damaged and the group of the cholangiopathies includes those conditions affecting the bile duct epithelium or the cholangiocytes. They can range from transient cholestasis to vanishing bile duct syndrome and sclerosing cholangitis, both leading eventually to the development of biliary fibrosis and cirrhosis. In this review article, we focus on the etiology, predisposing factors, clinical manifestations, and histopathological characteristics of bile duct injury as a consequence of drug treatment and discuss separately the different bile duct pathologies.
肝脏是药物代谢的主要场所,即机体解毒和消除药物的关键器官。因此,它经常受到有毒代谢物的影响,有时会导致致命后果。病理谱因主要受损的细胞类型而异,胆管疾病包括影响胆管上皮或胆管细胞的疾病。它们可以从短暂的胆汁淤积到消失的胆管综合征和硬化性胆管炎不等,最终都会导致胆管纤维化和肝硬化的发展。在这篇综述文章中,我们重点讨论了药物治疗引起的胆管损伤的病因、易患因素、临床表现和组织病理学特征,并分别讨论了不同的胆管疾病。